| - | 23 | Miscellaneous respiratory infections II | E-Posters in free access |
| - | 24 | Outcomes of anti-tuberculosis treatment | E-Posters in free access |
| - | 25 | Epidemiology of drug resistant tuberculosis | E-Posters in free access |
| - | 26 | Epidemiology of tuberculosis | E-Posters in free access |
| - | 27 | Screening and diagnosis of tuberculosis | E-Posters in free access |
| - | 28 | Difficult tuberculosis cases | E-Posters in free access |
| - | 29 | COPD – therapy/exacerbations | E-Posters in free access |
| - | 30 | COPD – inflammation/miscellaneous | E-Posters in free access |
| - | 31 | Lung cancer, haemoptoe, smoking and COPD | E-Posters in free access |
| - | 32 | Pulmonary embolism and hypertension | E-Posters in free access |
| - | 33 | Pneumothorax and pleural effusions | E-Posters in free access |
| - | 34 | Clinical problems: miscellaneous | E-Posters in free access |
| - | 35 | Clinical problems: miscellaneous II | E-Posters in free access |
| - | 36 | Assessment in COPD patients | E-Posters in free access |
| - | 37 | Assessment in the chronic patient | E-Posters in free access |
| - | 38 | Clinical features, rare metastases and rare tumors | E-Posters in free access |
| - | 39 | Screening, diagnosis, staging, prognosis, biological features | E-Posters in free access |
| - | 40 | Epidemiology, rare tumors (2), miscellaneous | E-Posters in free access |
| - | 41 | Clinical management of interstitial lung disease | E-Posters in free access |
| - | 42 | Airway cell biology II | E-Posters in free access |
| - | 43 | Therapies and management in chronic airway diseases | E-Posters in free access |
| 08:30 - 10:30 | 44 | Clinical year in review | Hot topics |
| 08:30 - 10:30 | 45 | Management of dynamic hyperinflation during exercise in COPD | Symposium |
| 08:30 - 10:30 | 46 | Web-based patient education | Symposium |
| 08:30 - 10:30 | 47 | Neurogenic inflammation – the link between nervous system and lung dysfunction | Symposium |
| 08:30 - 10:30 | 48 | Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? | Symposium |
| 08:30 - 10:30 | 49 | Clinical features and disease markers of sarcoidosis | Oral Presentation |
| 08:30 - 10:30 | 50 | Monitoring airway inflammation – exhaled markers vs induced sputum | Oral Presentation |
| 08:30 - 10:30 | 51 | Novel treatments for asthma | Oral Presentation |
| 08:30 - 10:30 | 52 | COPD and systemic inflammation | Oral Presentation |
| 08:30 - 10:30 | 53 | Advances in diagnosis and treatment of pulmonary diseases in children | Oral Presentation |
| 08:30 - 10:30 | 54 | Dealing with chronic allograft dysfunction: mission impossible? | Oral Presentation |
| 08:30 - 10:30 | 55 | New developments in the treatment and management of asthma | Oral Presentation |
| 08:30 - 10:30 | 56 | Markers of paediatric airway disease | Oral Presentation |
| 08:30 - 10:30 | 57 | Early detection, diagnosis, staging and clinical features of lung cancer | Electronic Poster Discussion |
| 08:30 - 10:30 | 58 | Clinical aspects of tuberculosis | Electronic Poster Discussion |
| 08:30 - 10:30 | 59 | Focus of care for tomorrow's allied health professionals | Poster Discussion |
| 08:30 - 10:30 | 60 | Innovative concepts in thoracic surgery | Poster Discussion |
| 08:30 - 10:30 | 61 | Immunological diagnosis of tuberculosis infection and disease | Poster Discussion |
| 08:30 - 10:30 | 62 | Novel research results in genetics and epidemiology of airway diseases | Poster Discussion |
| 10:45 - 12:45 | 63 | Radiology Grand Round: an interactive session | Major Symposium |
| 10:45 - 12:45 | 64 | Molecular pathology: an approach to lung diseases | Symposium |
| 10:45 - 12:45 | 65 | Difficult weaning from ventilator | Symposium |
| 10:45 - 12:45 | 66 | Tobacco control in Europe: what are the priorities? | Symposium |
| 10:45 - 12:45 | 67 | Mast cells and basophils as key effector cells in airway inflammation and remodelling | Symposium |
| 10:45 - 12:45 | 68 | Lung vascular and parenchymal remodeling | Oral Presentation |
| 10:45 - 12:45 | 69 | New features of paediatric asthma | Oral Presentation |
| 10:45 - 12:45 | 70 | Prognostic factors in lung cancer | Oral Presentation |
| 10:45 - 12:45 | 71 | Molecular airway biology | Oral Presentation |
| 10:45 - 12:45 | 72 | Virus-induced respiratory tract infection | Oral Presentation |
| 10:45 - 12:45 | 73 | Hot technologies in bronchoscopy and thoracoscopy | Oral Presentation |
| 10:45 - 12:45 | 74 | Landmark developments in lung function testing: 2006 | Oral Presentation |
| 10:45 - 12:45 | 75 | Signalisation in the pulmonary vasculature: new pathways and wrong signals | Oral Presentation |
| 10:45 - 12:45 | 76 | COPD comorbidity | Electronic Poster Discussion |
| 10:45 - 12:45 | 77 | Tuberculosis and other pulmonary infections | Electronic Poster Discussion |
| 10:45 - 12:45 | 78 | Diagnosis and treatment of tuberculosis | Poster Discussion |
| 10:45 - 12:45 | 79 | Exercise: respiratory mechanics and dynamic hyperinflation | Poster Discussion |
| 10:45 - 12:45 | 80 | Paediatric Respiratory Research Award | Symposium |
| 10:45 - 12:45 | 81 | COPD exacerbations | Poster Discussion |
| 12:45 - 14:45 | 82 | Educational seminar: the challenges of adapting education and training to the needs of tomorrow's doctors | Hot topics |
| 12:50 - 14:40 | 100 | Acute respiratory failure: diagnostic procedures and clinical management | Thematic Poster Session |
| 12:50 - 14:40 | 101 | Noninvasive mechanical ventilation in chronic respiratory failure – technical issues and outcome | Thematic Poster Session |
| 12:50 - 14:40 | 102 | Noninvasive mechanical ventilation in acute and chronic respiratory failure – a broad field | Thematic Poster Session |
| 12:50 - 14:40 | 103 | Pathogenic aspects of lung injury, destruction and repair | Thematic Poster Session |
| 12:50 - 14:40 | 104 | Diagnosis of obstructive sleep apnoea (OSA) | Thematic Poster Session |
| 12:50 - 14:40 | 105 | Clinical aspects of obstructive sleep apnoea (OSA) I | Thematic Poster Session |
| 12:50 - 14:40 | 106 | Spirometric assessment of lung pathophysiology | Thematic Poster Session |
| 12:50 - 14:40 | 107 | Recent update on asthma treatment | Thematic Poster Session |
| 12:50 - 14:40 | 108 | Evaluation of drugs for lung disease | Thematic Poster Session |
| 12:50 - 14:40 | 109 | Recent advances in treatment of COPD | Thematic Poster Session |
| 12:50 - 14:40 | 110 | Airway regulation, provocation and monitoring – I | Thematic Poster Session |
| 12:50 - 14:40 | 111 | Airway regulation, provocation and monitoring – II | Thematic Poster Session |
| 12:50 - 14:40 | 112 | Asthma models – mechanisms of airway inflammation and experimental therapies | Thematic Poster Session |
| 12:50 - 14:40 | 113 | Cellular mechanisms in the pathogenesis of asthma and rhinitis | Thematic Poster Session |
| 12:50 - 14:40 | 114 | Bronchial asthma and atopy – epidemiology, risk factors and risk assessment | Thematic Poster Session |
| 12:50 - 14:40 | 115 | New aspects in the pathogenesis of asthma | Thematic Poster Session |
| 12:50 - 14:40 | 116 | Asthma and allergy: prevalence, incidence and risk factors | Thematic Poster Session |
| 12:50 - 14:40 | 117 | Occupational asthma – causes, diagnosis & surveillance | Thematic Poster Session |
| 12:50 - 14:40 | 118 | Smoking cessation: why and how | Thematic Poster Session |
| 12:50 - 14:40 | 119 | Epidemiology of paediatric asthma and allergy | Thematic Poster Session |
| 12:50 - 14:40 | 120 | Paediatric asthma and quality of life | Thematic Poster Session |
| 12:50 - 14:40 | 121 | Markers of inflammation in paediatric asthma | Thematic Poster Session |
| 12:50 - 14:40 | 122 | Cystic fibrosis: aerosol treatment and non–pulmonary complications | Thematic Poster Session |
| 12:50 - 14:40 | 123 | Miscellaneous bronchial and other respiratory disorders in children | Thematic Poster Session |
| 12:50 - 14:40 | 124 | Paediatric epidemiology I: asthma phenotypes, risk factors and genetics | Thematic Poster Session |
| 12:50 - 14:40 | 125 | Surgical management for infectious and congenital disorder | Thematic Poster Session |
| 12:50 - 14:40 | 126 | Infection, trauma and emphysema | Thematic Poster Session |
| 12:50 - 14:40 | 127 | The evolving role of spirometry | Thematic Poster Session |
| 12:50 - 14:40 | 128 | Breath of life: assessing inflammation and obstruction in airways disease | Thematic Poster Session |
| 12:50 - 14:40 | 129 | Breathing patterns, respiratory muscles and training | Thematic Poster Session |
| 13:00 - 14:00 | 130 | MP1 – New strategies to improve exercise capacity in COPD | Meet the Professor |
| 13:00 - 14:00 | 131 | MP2 – How to organise a noninvasive ventilation unit | Meet the Professor |
| 13:00 - 15:00 | 134 | MP5 – How to use new immunosuppressive drugs in lung transplantation | Meet the Professor |
| 13:00 - 14:00 | 135 | MP6 – Pulmonary disorders and critical care of patients with HIV infection in the era of anti-retrovirals | Meet the Professor |
| 14:45 - 15:45 | 136 | The burden of pulmonary hypertension | Cournand Lecture |
| 14:45 - 16:45 | 137 | Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases | Symposium |
| 14:45 - 16:45 | 138 | Medical and surgical management of malignant pleuritis | Symposium |
| 14:45 - 16:45 | 140 | Implementation of the new standards on clinical pulmonary function testing | Symposium |
| 14:45 - 16:45 | 141 | Immunology of the airways | Oral Presentation |
| 14:45 - 16:45 | 142 | Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB) | Oral Presentation |
| 14:45 - 16:45 | 143 | Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management | Oral Presentation |
| 14:45 - 16:45 | 144 | Therapeutic effects in obstructive sleep apnoea | Oral Presentation |
| 14:45 - 16:45 | 145 | Highlights of epidemiology of COPD and lung function | Oral Presentation |
| 14:45 - 16:45 | 146 | How to treat tobacco smokers | Oral Presentation |
| 14:45 - 16:45 | 147 | Organisation and programmes in pulmonary rehabilitation | Oral Presentation |
| 14:45 - 16:45 | 148 | Immunological mechanisms in cell recruitment to the lungs | Oral Presentation |
| 14:45 - 16:45 | 149 | Epidemiology and treatment of tuberculosis | Electronic Poster Discussion |
| 14:45 - 16:45 | 150 | Clinical features of interstitial lung disease | Electronic Poster Discussion |
| 14:45 - 16:45 | 151 | Pneumonia and other invasive pulmonary infections in children | Poster Discussion |
| 14:45 - 16:45 | 152 | Recent advances in asthma treatment | Poster Discussion |
| 14:45 - 16:45 | 153 | Respiratory disease in primary care | Poster Discussion |
| 14:45 - 16:45 | 154 | Epidemiology, risk factors, co-morbidity and systemic side effects of asthma therapy | Poster Discussion |
| 15:45 - 16:45 | 155 | Outcomes for COPD pharmacological trials: from lung function to biomarkers | Symposium |